NASDAQBMRN
Year
View
| Form | Description | Date | Format |
|---|---|---|---|
| DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") | Apr 25, 2016 |     |
| DEFA14A | Additional proxy soliciting materials - definitive | Apr 25, 2016 | |
Search
Search
Innovative therapeutics
 |
DiseasesLysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS |
Products
Palynziq™ |
Patient/Physician Support Contact InformationBioMarin RareConnections™ Global Medical Information |